Key Points
—Kora Saúde, controlled by US private-equity fund HIG Capital, filed Wednesday night for an out-of-court restructuring covering roughly R$1.3 billion of financial debt at the holding level.
—Total net debt closed 2025 at R$2.5 billion, with the gross-debt-to-EBITDA ratio at roughly 8x — pushed up by interest costs after a debt-funded pandemic-era hospital acquisition spree.
—The 11,000-employee group is the largest private hospital operator in Espírito Santo, and the filing protects suppliers, customers, and patients while creditors of the holding company renegotiate terms.
Brazil’s high-rate cycle is now reaching the country’s mid-tier hospital chains, and the first big private-equity-owned operator just filed to renegotiate.
The Kora Saúde restructuring filing arrived in Brazilian court Wednesday night, with the Espírito Santo-based hospital operator seeking to renegotiate roughly R$1.3 billion of financial debt at the holding-company level. The company is controlled by US private-equity firm HIG Capital and trades on the B3 exchange under ticker KRSA3. Separate restructuring plans were filed for its subsidiaries, and the company said suppliers, customers, and patients will not be affected by the process.
The Rio Times, the Latin American financial news outlet, reports that Kora’s total net debt closed 2025 at R$2.5 billion. Fitch Ratings put the gross-debt-to-EBITDA ratio at roughly 8x for 2025 and projects 7.5x for 2026 — well above sector medians. The 2025 audit was delayed and ultimately released with a “material uncertainty” flag from auditors regarding going-concern.
What the Kora Saúde Restructuring Covers
Brazil’s out-of-court process — recuperação extrajudicial — requires the agreement of about one-third of debt holders, suspends payments, and lets the borrower negotiate terms without filing a full judicial reorganization. The plan targets non-operational debt at the holding level. Hospital operations continue normally, with payroll, supplier contracts, and patient billing untouched.
Before the filing, Kora had already secured two standstill agreements with debenture holders to defer interest payments due in March, and had been negotiating a broader rescheduling for months. Bloomberg first reported the company was preparing the move on April 1, citing sources familiar with the talks. The Wednesday filing crystallizes those talks into a formal court process and locks in temporary protection from acceleration clauses.
How the Kora Saúde Restructuring Got Here
Kora was built through aggressive acquisition between 2020 and 2022, when the Selic rate was at historic lows of 2% and Brazilian healthcare assets were trading at premium multiples. The company tapped debenture markets and bank credit to roll up regional hospitals across Espírito Santo, Mato Grosso, Tocantins, and Goiás. Once the Copom began hiking — eventually pushing Selic to 14.75% in late 2025 — financial expenses ballooned and squeezed operating margins.
Adjusted losses widened from R$2.7 million in 2024 to R$183.5 million in 2025, the company disclosed in its delayed annual report. CEO Antonio Benjamim had told NeoFeed in late 2023 that internalizing hospital services and selling real-estate assets would inject R$700 million in cash, but the program never closed the gap fast enough. HIG Capital had moved early in 2025 to delist the company through a tender offer, signaling the sponsor’s recognition that public-market scrutiny was constraining the workout.
What the Kora Saúde Restructuring Signals for Brazil’s PE Healthcare
Kora is not the first Brazilian healthcare LBO to crack under the rate cycle, but it is the largest hospital chain to file. Dasa, Hapvida-NotreDame, and Rede D’Or have managed their leverage through equity issuance and asset sales — Kora’s much smaller scale gave it less optionality. The filing follows a pattern visible across pandemic-vintage Brazilian leveraged deals, where R$2-5 billion mid-cap operators have hit refinancing walls at 14%+ Selic.
For investors tracking Brazil’s broader credit cycle, the Kora filing is a marker more than a shock — Raízen filed Brazil’s largest-ever extrajudicial restructuring at R$65 billion last week, and Agrogalaxy’s R$3.7 billion judicial recovery preceded both. The pattern is consistent: pandemic-era debt-funded growth, normalizing valuations, and a Selic still high enough to make rolling over expensive paper structurally unprofitable. The next 90 days will tell whether HIG Capital can negotiate haircuts that keep Kora viable, or whether the holding company moves toward a full judicial recovery.
Related Coverage
Latin America Economy 2026 → • Brazil Debt Trajectory • Brazil Elections 2026 Guide